Source:http://linkedlifedata.com/resource/pubmed/id/18279939
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2008-5-5
|
| pubmed:abstractText |
Pretreatment prostate specific antigen (PSA) is a strong predictor of prostate cancer outcome after radiotherapy and is a key parameter in pretreatment risk assessment. Because PSA is secreted from both benign and malignant tissue, a prior transurethral resection of prostate (TURP) may lower pretreatment PSA levels out of proportion to the extent of cancer. The purpose of this study was to determine whether a history of TURP is associated with increased biochemical failure (BF) after definitive radiotherapy for prostate cancer.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1527-9995
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
71
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
938-41
|
| pubmed:meshHeading |
pubmed-meshheading:18279939-Adenocarcinoma,
pubmed-meshheading:18279939-Adult,
pubmed-meshheading:18279939-Aged,
pubmed-meshheading:18279939-Aged, 80 and over,
pubmed-meshheading:18279939-Humans,
pubmed-meshheading:18279939-Male,
pubmed-meshheading:18279939-Middle Aged,
pubmed-meshheading:18279939-Prostate-Specific Antigen,
pubmed-meshheading:18279939-Prostatic Neoplasms,
pubmed-meshheading:18279939-Transurethral Resection of Prostate,
pubmed-meshheading:18279939-Treatment Failure,
pubmed-meshheading:18279939-Treatment Outcome
|
| pubmed:year |
2008
|
| pubmed:articleTitle |
Does transurethral resection of prostate (TURP) affect outcome in patients who subsequently develop prostate cancer?
|
| pubmed:affiliation |
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA.
|
| pubmed:publicationType |
Journal Article
|